Views | |
---|---|
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer | 11 |
November 2022 | December 2022 | January 2023 | February 2023 | March 2023 | April 2023 | May 2023 | |
---|---|---|---|---|---|---|---|
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer | 0 | 0 | 0 | 11 | 0 | 0 | 0 |
Views | |
---|---|
Palafox_nc_high.pdf | 5 |
Views | |
---|---|
United States | 9 |
Spain | 2 |
Views | |
---|---|
San Ramon | 5 |
Barcelona | 2 |
Redmond | 2 |
Ann Arbor | 1 |
San Diego | 1 |